BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Pharma & Biopharma Manufacturing

Connext Completes Phase 2 Enrollment of CNT201 for Dupuytren’s Contracture

All 56 planned participants enrolled approximately five months after first patient dosing - Topline Phase 2 data expected in late 2026 - Positive d...

August 19, 2026 | News

WuXi XDC Achieves GMP Release for First Overseas Bioconjugate Manufacturing Facility in Singapore

WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on t...

August 19, 2026 | News

JW Pharmaceutical’s Epaminurad Shows Statistical Superiority in Phase III Gout Trial

-JW Pharmaceutical (KRX:001060) announced that the multinational Phase 3 clinical trial of its gout treatment candidate ‘Epaminurad (code name U...

August 18, 2026 | News

Innovent, Daiichi Sankyo Partner to Commercialise Vanflyta for FLT3-ITD Positive AML in China

Collaboration to accelerate access to Vanflyta® for patients with newly diagnosed FLT3-ITD positive AML Innovent Bio...

August 11, 2026 | News

Porton Advanced Secures China Commercial Manufacturing Licence for Cell and Gene Therapy CDMO Services

Porton Advanced Solutions Ltd. ("Porton Advanced") has officially been granted a Drug Manufacturing License (Class C) by the National Medical Products Admi...

August 07, 2026 | News

Adneuris Licenses Cebranopadol Rights to Maruishi for Japan and South Korea

Agreement Grants Maruishi Rights for the Development and Commercialization of Cebranopadol for Pain in Japan and South Korea, Marking Adneuris' Second Ex...

August 07, 2026 | News

Enzene Launches NeX™ to Enable Local Biologics Manufacturing Worldwide

Enzene, a leading global continuously innovative development and manufacturing organization (CIDMO™), announced the launch of NeX™, a transform...

August 05, 2026 | News

From Market Access to Long-Term Growth: Rethinking Biopharma Expansion in APAC

BioPharma APAC speaks with Girisan Kariangal, Regional Vice President – Business Development & Alliance Management, Menarini Asia-Pacific, on the...

August 04, 2026 | Interaction

Advancing Freeze-to-Store Workflows for the Next Era of Biopharmaceutical Manufacturing

As biologics, biosimilars, and advanced cell and gene therapies continue to reshape the Asia-Pacific biopharmaceutical landscape, manufac...

August 03, 2026 | Expert Insight

7 Manufacturing Technologies Moving From Pilot to Plant in APAC

HOW THE SEVEN WERE CHOSEN Inclusion required evidence of at least two commercial-scale installations in the region, with sites named wherever publ...

August 03, 2026 | Analysis

Eppendorf to Invest EUR 40 Million in New Penang Manufacturing Facility

Eppendorf has signed an agreement for a new production site in Penang, Malaysia, marking the start of its planned greenfield manufacturing facility in Band...

July 30, 2026 | News

Navi Medical Secures A$6.8 Million to Commercialise Neonav® in US Paediatric Care

Melbourne- and Boston-based medical device company Navi Medical Technologies has closed a $A6.8 million capital raise to commercialise its breakthrough pae...

July 30, 2026 | News

8 APAC Assets That Went Global The Out-Licensing Class of 2025 to 2026

Business development teams across the region keep arriving at the same question, phrased slightly differently each time. What did a comparable asset, at a ...

July 29, 2026 | Analysis

Harbour BioMed and Sinopharm Form Strategic Alliance to Accelerate Innovative Biologics

Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunolo...

July 29, 2026 | News

Stay Connected